GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
Front-window bakery material. Catches the eye, delivers the goods.
Summary
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues including scarring, wrinkles, and hair loss. The article highlights that over 1.9 billion people worldwide suffer from skin conditions, yet current treatments like steroids and minoxidil only address symptoms rather than root causes. GeneSkin's approach uses advanced microneedle delivery for non-invasive treatment aimed at rejuvenating skin and hair by restoring stem cell function.
Key quotes
· 3 pulledMore than 1.9 billion worldwide suffer from some form of skin disease or cosmetic issue, including acne, eczema, scars, wrinkles, and hair loss.
Current treatments, such as steroids for raised scars and minoxidil for androgenetic alopecia, still only reduce specific symptoms, and are limited in their app
Using advanced microneedle delivery, our non-invasive treatments aim to reduce scarring, reverse aging, and promote hair growth, offering transformative solutions for millions worldwide.
You might also wanna read
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
boingboing.net·1d ago
Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·2d agoStartup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·2d ago
Penn researchers develop bioengineered chewing gum with potential to prevent oral and head cancers
Researchers at Penn, led by Dr. Henry Daniell, have developed a bioengineered chewing gum made from a bean plant that contains antiviral, an
whyy.org·3d ago
Personalized mRNA Cancer Vaccine Shows 49% Risk Reduction at 5-Year Follow-up
Moderna and Merck report promising 5-year follow-up results for their personalized mRNA cancer vaccine combined with Keytruda immunotherapy.
arstechnica.com·4mo ago
Company Develops Magnetically Controlled Antibody for Targeted Drug Delivery
A company called Nonfiction Labs has developed a remote-controlled antibody that can be turned on and off using a magnet. This breakthrough
bsky.app·4mo ago